| 08:30-08:50 | Keynote |
Recent Progress on Fluorescent Imaging Probes and Phototherapy |
|
||||
| 08:50-09:10 | Keynote |
Al-Powered Paradigm Shift in Future Visible Drug Development |
|
||||
| 09:10-09:25 | Invited |
Publish your findings with Nature Communications |
|
||||
| 09:25-09:40 | Invited |
Self-assembled nanomedicine for synergistic cancer phototherapy |
|
||||
| 09:40-09:50 | Oral Report |
Design, preparation, and evaluation of tumor diagnostic and therapeutic performance of piezoelectric/thermoelectric catalytic materials functionalized with oxygen-containing groups |
|
||||
| 09:50-10:00 | Oral Report |
Bio-Nano Recognition Mechanism of Nanostructures with Cellular Membrane |
|
||||
| 10:00-10:05 | Oral Report |
AI-guided development of LNPs for targeted mRNA delivery |
|
||||
| 10:05-10:30 | Other |
Coffee Break |
|||||
| 10:30-10:50 | Keynote |
Self-assembling dendrimer nanosystems for biomedical applications |
|
||||
| 10:50-11:10 | Keynote |
Intrinsically Radiolabeled Nanomaterials |
|
||||
| 11:10-11:25 | Invited |
Challenges in the development and clinical translation of RNA therapies |
|
||||
| 11:25-11:40 | Invited |
Construction of hybrid lipopeptides for tumor therapy and tissue regeneration |
|
||||
| 11:40-11:50 | Oral Report |
Targeting Labile Iron Pool to Inhibit Ferroptosis for Parkinson’s Disease Therapy by Engineered DFO-Nanosheets |
|
||||
| 11:50-11:55 | Oral Report |
Accurate Temperature-Feedback for NIR-II Fluorescence Imaging-Guided Thermal Immunotherapy |
|
||||
| 12:00-13:30 | Other |
Lunch |
|||||
| 13:30-13:50 | Keynote |
Engineering Metal Nanoclusters for Biomedical Applications |
|
||||
| 13:50-14:10 | Keynote |
Engineering nanoparticles for precision gene delivery into brain |
|
||||
| 14:10-14:25 | Invited |
Polymeric material for metal element delivery |
|
||||
| 14:25-14:40 | Oral Report |
Overcoming achille's heel of phototherapy for cancer theranostics |
|
||||
| 14:40-14:50 | Oral Report |
Ultrasound-driven piezoelectric catalysis and ion homeostasis regulation for tumor therapy |
|
||||
| 14:50-15:00 | Oral Report |
Liver-Targeted Lipid Nanoparticles for Immune Modulation: From Allergy Tolerance to Anti-Metastatic Immunotherapy |
|
||||
| 15:00-15:10 | Oral Report |
Impact of Shell Structure in Dendritic Nanogels on Antitumor Applications |
|
||||
| 15:10-15:20 | Oral Report |
Supramolecular Dendrimer Nanosystems to fight against antimicrobial resistance |
|
||||
| 15:20-15:30 | Oral Report |
New Opportunities for Neutrophil-based Nanomedicines |
|
||||
| 15:30-15:45 | Other |
Coffee Break |
|||||
| 15:45-16:05 | Keynote |
Key technological innovation and application of delivery systems for insoluble drugs |
|
||||
| 16:05-16:25 | Keynote |
Development and Evaluation of Metallic Nanoparticles for Bone Regeneration: From Cellular and Animal Models to Organs-on-chips |
|
||||
| 16:25-16:40 | Invited |
Rational design of endogenous targeting strategy to improve intratumor delivery |
|
||||
| 16:40-16:55 | Invited |
Physical therapy strategies based on materials and devices with assembled interfaces |
|
||||
| 16:55-17:10 | Invited |
Application of liposome encapsulation drug in inhibiting ferroptosis and reducing radiation damage during radiotherapy |
|
||||
| 17:10-17:20 | Oral Report |
Spatiotemporal Neuromodulation via Reversible and Photothermal-gated DNA Nanochannels |
|
||||